Biomarin Pharm (BMRN) Tops Q1 EPS by 8c; Guides In-line for FY Revenues
Tweet Send to a Friend
Biomarin Pharm (Nasdaq: BMRN) reports Q1 EPS of $0.08, 8 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
